📰 Ognitive Function News
Page 40 - Ognitive Function News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ognitive Function. Real-time updates on events, politics, business and more.
July 19, 2023
Researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and Dana Farber Cancer Institute in Boston have been awarded $7 million in total funding to study how diet and exercise impact mental and physical functioning in older cancer survivors and their caregivers.
July 19, 2023
While hearing aids and audiological support services did not have any impact on cognitive decline over 3 years in a general population of older adults, treating hearing loss protected against cognitive decline in older adults at greater risk of dementia.
July 19, 2023
Two additional studies define specific gut bacteria that are associated with increased dementia risk, as well as gut bacteria that may be neuroprotective.
July 18, 2023
An expert in human nutrition has called for a review of the guidelines for B-vitamin intakes during pregnancy, with significant evidence noting heightened requirements throughout and significant benefits to maternal and offspring health following prolonged supplementation.
July 18, 2023
Six new “Ingredients of the Year” were announced at the recent NutraIngredients-USA Awards spanning beauty from within, cognitive function, healthy aging, prebiotic, sports nutrition, and weight management. Read on to meet the winners…
July 18, 2023
A new review has unveiled the promising effects of phytochemical (PC) supplementation on sleep recovery and daytime fatigue, leading to enhanced physical performance.
July 17, 2023
Coya Therapeutics Inc (NASDAQ: COYA) reported results from an open-label proof-of-concept clinical study for low-dose interleukin 2 (ld IL-2) in patients with Alzheimer's disease (AD). The study enrolled eight patients with confirmed brain amyloid pathology and baseline Mini-Mental State Examination test (MMSE) scores, a measure of cognitive function, between 12 and 25. The patients were treated with five-day courses of subcutaneous ld IL-2 for four monthly cycles and were followed for two ...
July 14, 2023
Two pathologies drive the progression of Alzheimer's disease. Early on, amyloid beta plaques lead the way, but around the time cognitive symptoms arise, tau tangles take over as the driving force and cognition steadily declines.
July 13, 2023
Researchers evaluated the impacts of prolonged fluoride exposure during adolescence and adulthood on cognition and associated hippocampal alterations.
July 13, 2023
Omega-3 polyunsaturated fatty acids (n-3 PUFAs) have been found to have beneficial effects on inflammatory markers, metabolic dysregulation, and depressive symptoms.